Exercise-induced ischemia in newly diagnosed asymptomatic type 2 diabetes mellitus patients: a prospective observational study

Authors

DOI:

https://doi.org/10.64171/JAMS.2026.6.2.7-11

Keywords:

Type 2 diabetes mellitus, Silent ischemia, Treadmill test, HbA1c, Coronary artery disease, Asymptomatic diabetes

Abstract

Background: Cardiovascular disease remains the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). Coronary artery disease in diabetes may remain clinically silent until advanced stages because of autonomic dysfunction, altered pain perception, and diffuse atherosclerosis. Early recognition of occult ischemia may permit timely preventive intervention.

Objective: To determine the prevalence of exercise-induced ischemia using treadmill exercise testing in newly diagnosed asymptomatic T2DM patients and to identify associated clinical predictors.

Methods: This prospective observational study enrolled 200 newly diagnosed asymptomatic T2DM patients with normal resting electrocardiograms and no known coronary artery disease. All patients underwent detailed clinical evaluation, biochemical investigations, lipid profile assessment, and treadmill stress testing using the Bruce protocol.

Results: Of the 100 participants, 63% were male and 37% were female. The majority belonged to the 41–50 year age group. Mean body mass index was 24.71 ± 3.42 kg/m². Mean fasting blood glucose was 181.74 ± 33.80 mg/dL, postprandial blood glucose 229.35 ± 57.92 mg/dL, and HbA1c 8.63 ± 1.22%. Positive treadmill stress testing suggestive of exercise-induced ischemia was observed in 2% patients. HbA1c was significantly higher in treadmill-positive patients compared with treadmill-negative patients.

Conclusion: Exercise-induced ischemia was uncommon in newly diagnosed asymptomatic T2DM patients. Poor glycemic control was significantly associated with positive stress testing. Selective rather than universal screening may be more appropriate in this population.

References

American Diabetes Association Professional Practice Committee. Standards of care in diabetes 2026. Diabetes Care. 2026;49(Suppl 1):S216-S245. Available from: https://diabetesjournals.org/care/article/49/Supplement_1/S216

American Diabetes Association Professional Practice Committee. Standards of care in diabetes 2025. Diabetes Care. 2025;48(Suppl 1):S207-S238. Available from: https://diabetesjournals.org/care/article/48/Supplement_1/S207

Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus. Circulation. 2016;133:2459-2502. Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000339

Cosson E, et al. Silent myocardial ischemia and cardiac autonomic neuropathy in diabetes. Diabetes Metab. 2005;31:31-37. Available from: https://pubmed.ncbi.nlm.nih.gov/15784167/

Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: AHA statement. Circulation. 2013;128:873-934. Available from: https://www.ahajournals.org/doi/10.1161/CIR.0b013e31829b5b44

Khunti K, Kosiborod MN, Ray KK. Legacy benefits of glycemic control in diabetes with cardiovascular disease. Diabetes Care. 2025;48(Suppl 1):S207-S238. Available from: https://diabetesjournals.org/care/article/48/Supplement_1/S207

Cosentino F, Grant PJ, Aboyans V, et al. ESC Guidelines on diabetes, pre-diabetes and cardiovascular diseases. Eur Heart J. 2023;44:4043-4140. Available from: https://academic.oup.com/eurheartj/article/44/39/4043

Cardiovascular risk screening in asymptomatic diabetes mellitus. Cardiovasc Diabetol. 2025;24:266. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-025-0266

Norhammar A, et al. Diabetes mellitus and unstable coronary artery disease. Lancet. 2002;359:2140-2144. Available from: https://pubmed.ncbi.nlm.nih.gov/12057592/

Screening for asymptomatic coronary artery disease in diabetes: systematic review. BMC Cardiovasc Disord. 2016;16:90. Available from: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-016-0256-9

Faglia E, et al. Prevalence of silent myocardial ischemia in newly diagnosed type 2 diabetes. Acta Diabetol. 2002;39:113-117. Available from: https://pubmed.ncbi.nlm.nih.gov/12370724/

Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA guideline update for exercise testing. Circulation. 2002;106:1883-1892. Available from: https://www.ahajournals.org/doi/10.1161/01.CIR.0000034670.06526.15

Emerging role of HbA1c and cardiovascular risk in diabetes. Diabetes Care. 2024;47(Suppl 1):S179-S218. Available from: https://diabetesjournals.org/care/article/47/Supplement_1/S179

Young LH, Wackers FJT, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in type 2 diabetes: DIAD follow-up study. JAMA. 2009;301:1547-1555. Available from: https://jamanetwork.com/journals/jama/fullarticle/183804

Wackers FJT, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: DIAD study. Diabetes Care. 2004;27:1954-1961. Available from: https://diabetesjournals.org/care/article/27/8/1954

Downloads

Published

2026-05-12

How to Cite

[1]
L. S. Potluri and S. S. Pediredla, “Exercise-induced ischemia in newly diagnosed asymptomatic type 2 diabetes mellitus patients: a prospective observational study”, J. A. Med. Sci, vol. 6, no. 2, pp. 07–11, May 2026.

Issue

Section

Articles